CORC

在结果中检索

CORC

浏览/检索结果: 共428条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases 期刊论文
CANCER LETTERS, 2022, 卷号: 525, 页码: 170-178
作者:  Su, Shang;  Cao, Jingchen;  Meng, Xiangqi;  Liu, Ruihua;  Vander Ark, Alexandra
收藏  |  浏览/下载：53/0  |  提交时间：2022/01/04
Repressing MYC by targeting BET synergizes with selective inhibition of PI3K alpha against B cell lymphoma 期刊论文
CANCER LETTERS, 2022, 卷号: 524, 页码: 206-218
作者:  Chen, Zi-qi;  Cao, Zhe-rui;  Wang, Yi;  Zhang, Xi;  Xu, Lan
收藏  |  浏览/下载：53/0  |  提交时间：2021/12/16
CYH33  MYC  P300  BET  B cell lymphoma  PI3K  
LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo 期刊论文
CANCER SCIENCE, 2021, 页码: 12
作者:  Liu, Yingqiang;  Lai, Mengzhen;  Li, Shan;  Wang, Yanan;  Feng, Fang
收藏  |  浏览/下载：62/0  |  提交时间：2022/01/18
Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGF beta signaling 期刊论文
ONCOGENE, 2021, 页码: 10
作者:  Kong, Ya;  Zhang, Yutian;  Wang, Hanlin;  Kan, Weijuan;  Guo, Haoran
收藏  |  浏览/下载：51/0  |  提交时间：2022/01/04
Oxidized Low-Density Lipoprotein Links Hypercholesterolemia and Bladder Cancer Aggressiveness by Promoting Cancer Stemness 期刊论文
CANCER RESEARCH, 2021, 卷号: 81, 期号: 22, 页码: 5720-5732
作者:  Yang, Lin;  Sun, Jingya;  Li, Meiqian;  Long, Yiming;  Zhang, Dianzheng
收藏  |  浏览/下载：23/0  |  提交时间：2022/01/04
The Novel RET Inhibitor SYHA1815 Inhibits RET-Driven Cancers and Overcomes Gatekeeper Mutations by Inducing G1 Cell-Cycle Arrest through c-Myc Downregulation 期刊论文
MOLECULAR CANCER THERAPEUTICS, 2021, 卷号: 20, 期号: 11, 页码: 2198-2206
作者:  Jiang, Yuchen;  Peng, Xia;  Ji, Yinchun;  Dai, Yang;  Fang, Yanfen
收藏  |  浏览/下载：30/0  |  提交时间：2021/12/16
Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020) 期刊论文
MOLECULAR CANCER, 2021, 卷号: 20, 期号: 1, 页码: 1
作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang
收藏  |  浏览/下载：58/0  |  提交时间：2021/11/04
Preclinical characterization of LOXO-338, a novel, oral and selective BCL2 inhibitor. 期刊论文
CANCER RESEARCH, 2021, 卷号: 81, 期号: 13, 页码: 1
作者:  Brandhuber, Barbara;  Ku, Karin;  Lallena, Maria J.;  Baquero, Carmen;  Choy, Regina
收藏  |  浏览/下载：12/0  |  提交时间：2021/11/04
A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-kappa B pathway 期刊论文
CANCER CELL INTERNATIONAL, 2021, 卷号: 21, 期号: 1, 页码: 10
作者:  Gao, Xuejie;  Li, Bo;  Ye, Anqi;  Wang, Houcai;  Xie, Yongsheng
收藏  |  浏览/下载：22/0  |  提交时间：2021/08/17
lncRNA H19 binds VGF and promotes pNEN progression via PI3K/AKT/CREB signaling (vol 26, pg 643, 2019) 期刊论文
ENDOCRINE-RELATED CANCER, 2021, 卷号: 28, 期号: 4, 页码: X1-X2
作者:  Ji, Meng;  Yao, Yanli;  Liu, Anan;  Shi, Ligang;  Chen, Danlei
收藏  |  浏览/下载：18/0  |  提交时间：2021/08/17

©版权所有 ©2017 CSpace - Powered by CSpace